Relay Therapeutics Inc (NQ: RLAY )
7.200
+0.260
(+3.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Relay Therapeutics Inc
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](/next-assets/images/schema-image-default.png)
Relay Therapeutics's Return On Capital Employed Overview
March 01, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](/next-assets/images/schema-image-default.png)
Relay Therapeutics Earnings Preview
February 22, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4781.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_27511.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
February 03, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_3423.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_123.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
November 07, 2022
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/12/19/image_2.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9408.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5838.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4704.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022
September 30, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image_1.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image-tesla3.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_16868.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/14/image_4.jpg?width=1200&height=800&fit=crop)
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
September 14, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/13/doctor-563429.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image27.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/13/image17_0.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.